by Eric Christianson | Mar 24, 2024 | Cardiovascular Case Studies
An 89-year-old female has a history of hypertension, atrial fibrillation, stroke, GERD, osteoporosis, and osteoarthritis. Her current medication list includes the following: Amlodipine (podcast) 5 mg daily Rivaroxaban (podcast) 20 mg daily Clonidine (podcast) 0.2 mg...
by Eric Christianson | Jan 3, 2024 | Cardiovascular Case Studies
In this hypertension case study, JD is a 64-year-old male who has a history of hypertension, GERD, gout, diabetes, constipation, and sexual dysfunction and presents with the following medication list. Hydrochlorothiazide 25 mg daily Amlodipine 5 mg daily Omeprazole 20...
by Eric Christianson | Apr 23, 2023 | Cardiovascular Case Studies, Infectious Disease and Oncology Case Studies
One thing I always encourage is critical thinking. Reviewing a diagnosis list will give you clues as to the likely medications that a patient is taking or should be taking if they are following guideline-based medication therapy. In this Bactrim CHF case study, I...
by Eric Christianson | Aug 1, 2021 | Cardiovascular Case Studies, Educational Case Studies For Pharmacists
In this article, I wanted to share information on tapering clonidine. This drug can cause serious rebound hypertension when abruptly discontinued and patients may not understand or realize that this risk exists. Here’s a case scenario that demonstrates tapering...
by Eric Christianson | Apr 4, 2021 | Cardiovascular Case Studies, Educational Case Studies For Pharmacists
Amiodarone is an older antiarrhythmic drug that you may see used in primary care and geriatrics. I’m well into my latest project on a NEW BOOK involving the prescribing cascade and polypharmacy. I wanted to share a part of it by discussing amiodarone adverse...
by Eric Christianson | Mar 14, 2021 | Cardiovascular Case Studies, Educational Case Studies For Pharmacists
Diuretics are a medication that I see used on a daily basis. I also encounter these medications causing adverse effects. With adverse effects comes the potential for providers to add medications to treat those adverse effects. Here’s a few examples I’ve...
